Impella CP (Abiomed) for use in adult patients with cardiogenic shock
HAYES, Inc
Record ID 32018000011
English
Authors' recommendations:
Cardiogenic shock (CS) is an acute life-threatening condition resulting from inadequate blood circulation due to the inability of the heart (most often the left ventricle) to adequately meet systemic tissue demands for oxygen and nutrients.
Technology Description:
The Impella CP is an intravascular nonpulsatile axial blood pump designed to support the circulatory system during CS, low output syndrome, or other conditions. Typically, it is inserted percutaneously through the
femoral artery and threaded into the left ventricle where it pumps blood from the left ventricle into the aorta. The Impella CP has a 14 Fr diameter and pumps at a rate of 3 to 4 liters per minute (L/min).
Patient Population:
The Impella CP is intended for short-term use (< 4 days) for the treatment of ongoing CS that occurs within 48 hours following AMI or open heart surgery as a result of isolated left ventricular failure that is unresponsive to optimal medical management and conventional treatment measures of pressors, inotropic agents, and intra-aortic balloon pump.
Details
Project Status:
Completed
Year Published:
2017
URL for published report:
The report may be purchased from:
http://www.hayesinc.com/hayes/crd/?crd=71106
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Heart-Assist Devices
- Humans
- Intra-Aortic Balloon Pumping
- Shock, Cardiogenic
Contact
Organisation Name:
HAYES, Inc.
Contact Address:
157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
saleinfo@hayesinc.com
Contact Email:
saleinfo@hayesinc.com
Copyright:
Winifred S. Hayes, Inc
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.